Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAIREA Regulatory News (AIEA)

Share Price Information for AIREA (AIEA)

Share Price is delayed by 15 minutes
Get Live Data
28.50    0.00 (0.00%)
Bid:
27.00
Ask:
30.00
Spread: 3.00 (11.111%)
Market Cap: £10.99m
AIEA Live PriceLast checked at - London Stock Exchange

Intraday AIREA Share Chart

Director/PDMR Shareholding

28 Apr 2009 17:56

RNS Number : 3250R
Airea PLC
28 April 2009
 

28 April 2009

AIREA plc ('the Company')

Director Shareholding

The Company was notified today that Martin Toogood, a non-executive director, purchased the following ordinary 25p shares in the Company ('Ordinary Shares'). 

Bargain Date

Quantity

Security name

Price (pence)

Total cost (£)

21/04/09

75,000

Airea plc Ordinary £0.25

9.0

6,927.88

23/04/09

200,000

Airea plc Ordinary £0.25

19.5

39,609.75

24/04/09

75,000

Airea plc Ordinary £0.25

19.5

14,748.78

27/04/09

50,000

Airea plc Ordinary £0.25

19.5

9,860.00

As a result of this transaction Martin Toogood has a beneficial interest in the Company of 400,000 Ordinary Shares representing 0.9% of the issued share capital of the Company.

For further information please contact:

AIREA plc

Neil Rylance Chief Executive Officer 01924-266561

Kevin Henry Group Finance Director 01924-266561

 

Brewin Dolphin Investment Banking

Andrew Kitchingman Managing Director - Corporate Finance 0845-2134730

Sean Wyndham-Quin Assistant Director - Corporate Finance 0845-2134747

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQVLFLKZBEBBE
Date   Source Headline
6th May 20263:06 pmRNSResult of AGM
6th May 20262:00 pmRNSAGM Statement
20th Apr 202612:23 pmRNSDirector/PDMR Dealing
26th Mar 20267:00 amRNSFinal Results for the year ended 31 December 2025
9th Mar 20267:00 amRNSNotice of Results
11th Feb 20268:52 amRNSHolding(s) in Company
22nd Jan 20267:00 amRNSPre-close Trading Update
1st Oct 20259:08 amRNSHolding(s) in Company
30th Sep 20254:12 pmRNSDivestment of Investment Property
30th Sep 20257:00 amRNSInterim Results
29th Jul 20257:00 amRNSPre-close Trading Update and Notice of Results
7th May 20253:06 pmRNSResult of AGM
7th May 202512:01 pmRNSDirector/PDMR Dealing
7th May 202512:00 pmRNSAGM Statement
28th Mar 20257:00 amRNSDirector/PDMR Dealings
27th Mar 20257:00 amRNSFinal Results for the year ended 31 December 2024
10th Mar 20257:00 amRNSNotice of Results
30th Jan 20257:00 amRNS-ROpening of Dubai Showroom
23rd Jan 202510:40 amRNSHolding(s) in Company
23rd Jan 20257:00 amRNSPre-close Trading Update
26th Sep 202411:43 amRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSInterim Results
6th Aug 20247:00 amRNSPre-close Trading Update and Notice of Results
28th Jun 20247:00 amRNSLong Term Incentive Plan Awards
8th May 20243:07 pmRNSResult of AGM
8th May 202412:00 pmRNSAGM Statement
26th Mar 20247:00 amRNSFinal Results for the year ended 31 December 2023
11th Mar 20247:00 amRNSNotice of Results
24th Jan 20247:00 amRNSTrading update and £5.0m investment in facility
3rd Oct 20237:00 amRNSAppointment of Chief Financial Officer
28th Jul 202310:30 amRNSHolding(s) in Company
27th Jul 20237:00 amRNSInterim Results
4th Jul 20233:00 pmRNSDirectorate Change
22nd Jun 20237:00 amRNSHolding(s) in Company
10th May 20232:56 pmRNSResult of AGM
10th May 202312:00 pmRNSAGM Statement
10th May 20237:00 amRNSAppointment of Independent Non-Executive Director
13th Apr 20233:42 pmRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSFinal Results for the year ended 31 December 2022
16th Dec 20227:00 amRNSLong Term Incentive Plan Awards
7th Dec 20224:59 pmRNSHolding(s) in Company
25th Aug 20227:00 amRNSAppointment of Chief Executive
29th Jul 20221:54 pmRNSHolding(s) in Company
28th Jul 20227:00 amRNSInterim Report
24th May 20223:02 pmRNSRe Dividend
17th May 20224:01 pmRNSResult of AGM
12th Apr 20227:00 amRNSFinal Results for the year ended 31 December 2021
29th Mar 20224:40 pmRNSDeath of a Director
18th Mar 20224:45 pmRNSDirector's Leave of Absence
15th Nov 20217:00 amRNSChange of Auditor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.